Browsing Tag
CONMED Corporation
2 posts
Why CONMED’s (NYSE: CNMD) reported sale review could reset the medtech value debate after Q2
CONMED’s sale speculation, Q2 results and AirSeal update put CNMD back in focus. Read how medtech M&A interest could reshape its turnaround story.
CONMED names John Gallagher as CFO as $CNMD faces refinancing and execution test
CONMED appoints John Gallagher as CFO while CNMD nears a 52-week low and prepares to refinance debt. Read what his arrival means for investors and strategy.